Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 11.12%3.54B | 15.94%955.07M | 13.27%874.34M | 12.76%853.04M | 2.91%862.31M | 2.41%3.19B | 823.74M | 771.91M | 756.48M | 837.91M |
Cost of revenue | 11.18%1.96B | 18.12%512.14M | 11.84%470.18M | 4.18%477.98M | 11.02%496.98M | 3.81%1.76B | 433.58M | 420.4M | 458.79M | 447.66M |
Gross profit | 11.04%1.59B | 13.52%442.93M | 14.98%404.16M | 25.99%375.06M | -6.38%365.33M | 0.73%1.43B | 390.17M | 351.51M | 297.69M | 390.24M |
Operating expense | 7.51%1.04B | 6.26%258.51M | 3.54%255.07M | 10.68%262.81M | 9.68%265.77M | 6.87%969.37M | 243.27M | 246.35M | 237.44M | 242.31M |
Staff costs | 12.75%474.48M | 13.32%122.95M | 17.56%116.33M | 9.23%116.76M | 11.22%118.44M | 4.00%420.83M | --108.5M | --98.95M | --106.9M | --106.49M |
Selling and administrative expenses | 1.07%118.25M | -5.04%-308.99M | -6.24%136.86M | 7.43%144.04M | 11.61%146.34M | -76.65%117M | ---294.15M | --145.96M | --134.08M | --131.11M |
-General and administrative expense | 1.07%118.25M | -5.04%-308.99M | -6.24%136.86M | 7.43%144.04M | 11.61%146.34M | -76.65%117M | ---294.15M | --145.96M | --134.08M | --131.11M |
Other operating expenses | 4.15%449.43M | 3.64%444.55M | 31.18%1.89M | 156.72%2.01M | -78.96%991K | 33,719.36%431.54M | --428.92M | --1.44M | ---3.54M | --4.71M |
Operating profit | 18.48%545.32M | 25.54%184.42M | 41.76%149.08M | 86.31%112.25M | -32.70%99.56M | -10.14%460.25M | 146.9M | 105.17M | 60.25M | 147.93M |
Net non-operating interest income (expenses) | 220.73%460K | 2,412.50%402K | 483.33%23K | 108.55%20K | 109.55%15K | 71.65%-381K | 16K | -6K | -234K | -157K |
Non-operating interest income | 242.25%486K | 2,512.50%418K | 500.00%24K | --23K | -84.09%21K | 10.94%142K | --16K | ---6K | --0 | --132K |
Non-operating interest expense | -95.03%26K | --16K | --1K | -98.72%3K | -97.92%6K | -64.47%523K | --0 | --0 | --234K | --289K |
Net investment income | 176.12%6.63M | 27.19%12.18M | 231.96%8.54M | 3.48%-11.81M | 73.62%-2.27M | -81.37%-8.71M | 9.57M | 2.57M | -12.24M | -8.62M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | -96.59%1.7M | 86.28%1.18M | 0 | 0 | 520K | 8,409.83%49.86M | 634K | 38.73M | 10.5M | 0 |
Less:Other special charges | 98.94%-520K | --0 | --0 | --0 | ---520K | -8,259.83%-48.96M | --266K | ---38.73M | ---- | ---- |
Less:Write off | -31.22%-1.18M | ---- | ---- | ---- | ---- | ---900K | ---- | ---- | ---- | ---- |
Other non-operating income (expenses) | 109.70%1.76M | -687.00%-9.89M | 181.92%6.05M | 121.09%4.69M | 303.08%915K | -247.01%-18.17M | 1.69M | 2.15M | -22.23M | 227K |
Income before tax | 15.12%555.88M | 18.56%188.3M | 10.16%163.69M | 191.62%105.15M | -29.16%98.74M | -6.75%482.85M | 158.82M | 148.6M | 36.06M | 139.38M |
Income tax | 17.12%169.47M | -34.47%24.02M | 32.43%60.98M | 75.71%29.58M | 21.56%54.89M | -12.81%144.69M | 36.66M | 46.05M | 16.83M | 45.15M |
Net income | 14.27%386.41M | 34.48%164.27M | 0.16%102.71M | 293.12%75.57M | -53.46%43.85M | -3.89%338.16M | 122.16M | 102.55M | 19.22M | 94.23M |
Net income continuous operations | 14.27%386.41M | 34.48%164.27M | 0.16%102.71M | 293.10%75.57M | -53.46%43.85M | -3.89%338.16M | --122.16M | --102.55M | --19.23M | --94.23M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 14.27%386.41M | 34.48%164.27M | 0.16%102.71M | 293.12%75.57M | -53.46%43.85M | -3.89%338.16M | 122.16M | 102.55M | 19.22M | 94.23M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 14.27%386.41M | 34.48%164.27M | 0.16%102.71M | 293.12%75.57M | -53.46%43.85M | -3.89%338.16M | 122.16M | 102.55M | 19.22M | 94.23M |
Gross dividend payment | ||||||||||
Basic earnings per share | 4.47%39.755 | 30.16%16.895 | -4.26%10.57 | 244.56%7.775 | -61.67%4.515 | -13.47%38.055 | 12.98 | 11.04 | 2.2565 | 11.7785 |
Diluted earnings per share | 4.76%38.97 | 29.74%16.555 | -3.99%10.36 | 284.74%7.625 | -62.39%4.43 | -15.42%37.2 | 12.76 | 10.79 | 1.9819 | 11.7785 |
Dividend per share | 66.67%17.5 | 66.67%17.5 | 0 | 0 | 0 | 10.5 | 10.5 | |||
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |